BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2982638)

  • 1. Leishmania mexicana: enzyme activities of amastigotes and promastigotes and their inhibition by antimonials and arsenicals.
    Mottram JC; Coombs GH
    Exp Parasitol; 1985 Apr; 59(2):151-60. PubMed ID: 2982638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania mexicana: subcellular distribution of enzymes in amastigotes and promastigotes.
    Mottram JC; Coombs GH
    Exp Parasitol; 1985 Jun; 59(3):265-74. PubMed ID: 3158538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes.
    Ephros M; Waldman E; Zilberstein D
    Antimicrob Agents Chemother; 1997 May; 41(5):1064-8. PubMed ID: 9145870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of Leishmania mexicana amastigotes and promastigotes. Enzyme activities and subcellular locations.
    Coombs GH; Craft JA; Hart DT
    Mol Biochem Parasitol; 1982 Mar; 5(3):199-211. PubMed ID: 6211617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemistry of Pentostam resistant Leishmania.
    Berman JD; Edwards N; King M; Grogl M
    Am J Trop Med Hyg; 1989 Feb; 40(2):159-64. PubMed ID: 2537584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of particulate malate dehydrogenase and phosphoenolpyruvate carboxykinase from Leishmania mexicana mexicana.
    Mottram JC; Coombs GH
    Biochim Biophys Acta; 1985 Mar; 827(3):310-9. PubMed ID: 3970941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.
    Ephros M; Bitnun A; Shaked P; Waldman E; Zilberstein D
    Antimicrob Agents Chemother; 1999 Feb; 43(2):278-82. PubMed ID: 9925518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tissue culture system for the growth of several species of Leishmania: growth kinetics and drug sensitivities.
    Martinez S; Looker DL; Marr JJ
    Am J Trop Med Hyg; 1988 Mar; 38(2):304-7. PubMed ID: 2833127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate.
    Berman JD; Waddell D; Hanson BD
    Antimicrob Agents Chemother; 1985 Jun; 27(6):916-20. PubMed ID: 2411217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis.
    Martinez S; Looker DL; Berens RL; Marr JJ
    Am J Trop Med Hyg; 1988 Sep; 39(3):250-5. PubMed ID: 2845824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid beta-oxidation in Leishmania mexicana amastigotes.
    Berman JD; Gallalee JV; Best JM
    Biochem Pharmacol; 1987 Jan; 36(2):197-201. PubMed ID: 3028425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation and limited proliferation of isolated Leishmania mexicana amastigotes at 27 degrees C.
    Taylor DR; Williams GT
    Acta Trop; 1991 Dec; 50(2):141-50. PubMed ID: 1685870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania major LmACR2 is a pentavalent antimony reductase that confers sensitivity to the drug pentostam.
    Zhou Y; Messier N; Ouellette M; Rosen BP; Mukhopadhyay R
    J Biol Chem; 2004 Sep; 279(36):37445-51. PubMed ID: 15220340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro micromethod for drug sensitivity testing of Leishmania.
    Jackson JE; Tally JD; Tang DB
    Am J Trop Med Hyg; 1989 Sep; 41(3):318-30. PubMed ID: 2552851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents.
    Walker J; Saravia NG
    J Parasitol; 2004 Oct; 90(5):1155-62. PubMed ID: 15562618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action.
    Sereno D; Cavaleyra M; Zemzoumi K; Maquaire S; Ouaissi A; Lemesre JL
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3097-102. PubMed ID: 9835497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucantime resistant Leishmania promastigotes are sensitive to pentostam.
    Moreira ES; Guerra JB; Petrillo-Peixoto Mde L
    Rev Soc Bras Med Trop; 1992; 25(4):247-50. PubMed ID: 1340539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antileishmanial properties of tri- and pentavalent antimonial preparations.
    Roberts WL; Berman JD; Rainey PM
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1234-9. PubMed ID: 7574507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania mexicana: drug sensitivities of promastigotes and transforming amastigotes.
    Coombs GH; Hart DT; Capaldo J
    J Antimicrob Chemother; 1983 Feb; 11(2):151-62. PubMed ID: 6833171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania mexicana: purine-metabolizing enzymes of amastigotes and promastigotes.
    Hassan HF; Coombs GH
    Exp Parasitol; 1985 Apr; 59(2):139-50. PubMed ID: 2982637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.